Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer.

N, Hoosein; M, Abdul; R, McCabe; E, Gero; L, Deftos; M, Banks; S, Hodges; L, Finn; C, Logothetis

doi:10.1016/1078-1439(96)00012-9

Public

Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer.

Shared by NobleBlocks on Nov 1, 1995 • 12:00 AM UTC

Authors:

Hoosein N

Abdul M

McCabe R

Abstract

Serum biomarkers that reflect the complex pathways of cancer progression have contributed to the clinical understanding of many malignancies. Recent studies have suggested that certain neuroendocrine (NE) elements participate in prostate cancer (PCa) progression. Interleukin-6 (IL-6) may serve as a ...

Discussions